Davide Campari-Milano N.V. (FRA:58H)
Germany · Delayed Price · Currency is EUR 6.06
+0.02 (0.33%)
Last updated: Aug 1, 2025
Blueprint Medicines Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 3,074 | 3,070 | 2,919 | 2,698 | 2,173 | 1,772 | Upgrade |
Other Revenue | -0.1 | -0.1 | - | - | - | - | Upgrade |
| 3,074 | 3,070 | 2,919 | 2,698 | 2,173 | 1,772 | Upgrade | |
Revenue Growth (YoY) | 3.02% | 5.18% | 8.19% | 24.16% | 22.61% | -3.83% | Upgrade |
Cost of Revenue | 1,284 | 1,303 | 1,219 | 1,109 | 875.8 | 746.1 | Upgrade |
Gross Profit | 1,790 | 1,767 | 1,700 | 1,589 | 1,297 | 1,026 | Upgrade |
Selling, General & Admin | 1,205 | 1,173 | 1,096 | 1,041 | 861.6 | 704.2 | Upgrade |
Other Operating Expenses | -13.6 | - | - | - | 15.4 | 34.1 | Upgrade |
Operating Expenses | 1,191 | 1,173 | 1,096 | 1,041 | 877 | 738.3 | Upgrade |
Operating Income | 599.3 | 593.9 | 604.3 | 547.5 | 419.9 | 287.6 | Upgrade |
Interest Expense | -127.4 | -110.1 | -70.8 | -31.5 | -28.3 | -35.4 | Upgrade |
Interest & Investment Income | 38 | 38 | 23.5 | 15.1 | 11.9 | 6.3 | Upgrade |
Earnings From Equity Investments | -58.9 | -59.5 | -8.3 | -6.6 | -0.1 | -2.8 | Upgrade |
Currency Exchange Gain (Loss) | -9 | -9 | -19.2 | -4.6 | 7.9 | -4.1 | Upgrade |
Other Non Operating Income (Expenses) | -7.9 | -7.8 | -7.8 | -9.6 | -4.2 | -3.4 | Upgrade |
EBT Excluding Unusual Items | 434.1 | 445.5 | 521.7 | 510.3 | 407.1 | 248.2 | Upgrade |
Merger & Restructuring Charges | -140.8 | -140.8 | -36.6 | -11.4 | -10.6 | -9.7 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | - | - | -1.3 | -0.6 | Upgrade |
Asset Writedown | -56.8 | -56.8 | -11.9 | -6.6 | -8 | -45.7 | Upgrade |
Other Unusual Items | 2.2 | 7.7 | -6.7 | -17.3 | -3.4 | 17.4 | Upgrade |
Pretax Income | 238.7 | 255.6 | 466.5 | 475 | 388.6 | 209.6 | Upgrade |
Income Tax Expense | 57 | 63 | 134 | 143.5 | 105.6 | 22.7 | Upgrade |
Earnings From Continuing Operations | 181.7 | 192.6 | 332.5 | 331.5 | 283 | 186.9 | Upgrade |
Minority Interest in Earnings | 6.6 | 9 | -2 | 1.5 | 1.8 | 1 | Upgrade |
Net Income | 188.3 | 201.6 | 330.5 | 333 | 284.8 | 187.9 | Upgrade |
Net Income to Common | 188.3 | 201.6 | 330.5 | 333 | 284.8 | 187.9 | Upgrade |
Net Income Growth | -43.50% | -39.00% | -0.75% | 16.92% | 51.57% | -39.07% | Upgrade |
Shares Outstanding (Basic) | 1,201 | 1,200 | 1,128 | 1,126 | 1,127 | 1,134 | Upgrade |
Shares Outstanding (Diluted) | 1,258 | 1,251 | 1,139 | 1,140 | 1,146 | 1,156 | Upgrade |
Shares Change (YoY) | 5.41% | 9.79% | -0.09% | -0.53% | -0.86% | -1.16% | Upgrade |
EPS (Basic) | 0.16 | 0.17 | 0.29 | 0.30 | 0.25 | 0.17 | Upgrade |
EPS (Diluted) | 0.16 | 0.17 | 0.29 | 0.29 | 0.25 | 0.16 | Upgrade |
EPS Growth | -45.00% | -42.09% | - | 16.00% | 56.25% | -38.46% | Upgrade |
Free Cash Flow | 365.3 | 246.3 | -136.9 | 41.8 | 362.7 | 208.2 | Upgrade |
Free Cash Flow Per Share | 0.29 | 0.20 | -0.12 | 0.04 | 0.32 | 0.18 | Upgrade |
Dividend Per Share | - | 0.065 | 0.065 | 0.060 | 0.060 | 0.055 | Upgrade |
Dividend Growth | - | - | 8.33% | - | 9.09% | - | Upgrade |
Gross Margin | 58.23% | 57.55% | 58.25% | 58.89% | 59.69% | 57.89% | Upgrade |
Operating Margin | 19.50% | 19.35% | 20.71% | 20.30% | 19.33% | 16.23% | Upgrade |
Profit Margin | 6.13% | 6.57% | 11.32% | 12.34% | 13.11% | 10.60% | Upgrade |
Free Cash Flow Margin | 11.88% | 8.02% | -4.69% | 1.55% | 16.69% | 11.75% | Upgrade |
EBITDA | 708.1 | 686.6 | 682.2 | 607.6 | 471.8 | 338.1 | Upgrade |
EBITDA Margin | 23.03% | 22.37% | 23.37% | 22.52% | 21.71% | 19.08% | Upgrade |
D&A For EBITDA | 108.8 | 92.7 | 77.9 | 60.1 | 51.9 | 50.5 | Upgrade |
EBIT | 599.3 | 593.9 | 604.3 | 547.5 | 419.9 | 287.6 | Upgrade |
EBIT Margin | 19.49% | 19.35% | 20.71% | 20.30% | 19.33% | 16.23% | Upgrade |
Effective Tax Rate | 23.88% | 24.65% | 28.72% | 30.21% | 27.17% | 10.83% | Upgrade |
Revenue as Reported | 3,070 | 3,070 | 2,919 | 2,698 | 2,173 | 1,772 | Upgrade |
Advertising Expenses | - | 513.3 | 494.1 | 479 | 397.8 | 309.8 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.